Free tool
FAERS Monitor: Phexx
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 208352 or its brand name (Phexx, Citric Acid, Lactic Acid, Potassium Bitartrate). Reports on generic versions are filed under their own applications.
Reports
181
Serious
71
39% of reports
Hospitalization
8
Death reported
0
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug ineffective59
- pregnancy59
- abortion spontaneous19
- vulvovaginal burning sensation18
- pregnancy on contraceptive14
- product administration error14
- complication of device insertion6
- expired product administered6
- nausea6
- vaginal discharge6
- vaginal haemorrhage6
- abdominal pain5
- burning sensation5
- ectopic pregnancy5
- vulvovaginal pain5
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2020 | 1 |
| 2021 | 36 |
| 2022 | 61 |
| 2023 | 35 |
| 2024 | 29 |
| 2025 | 8 |
| 2026 | 11 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,978 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| pregnancy on contraceptiveSignal | 14 | 1125.4 | 678.7 | 14,484 |
| vulvovaginal burning sensationSignal | 18 | 343.7 | 221.5 | 5,797 |
| pregnancySignal | 59 | 343.5 | 278.4 | 19,765 |
| ectopic pregnancySignal | 5 | 189.3 | 79.7 | 756 |
| vulvovaginal painSignal | 5 | 120.7 | 50.8 | 480 |
| product administration errorSignal | 14 | 80.6 | 48.7 | 1,022 |
| vaginal dischargeSignal | 6 | 68.9 | 31.4 | 337 |
| abortion spontaneousSignal | 19 | 55.1 | 36.0 | 958 |
| complication of device insertionSignal | 6 | 35.1 | 16.0 | 166 |
| expired product administeredSignal | 6 | 21.0 | 9.6 | 95 |
| vaginal haemorrhageSignal | 6 | 16.1 | 7.3 | 71 |
| burning sensationSignal | 5 | 8.3 | 3.5 | 25 |
| drug ineffectiveSignal | 59 | 5.2 | 4.2 | 209 |
| abdominal pain | 5 | 2.5 | 1.1 | 3 |
| nausea | 6 | 0.9 | 0.4 | 0 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.